Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples
Aleksandr Ianevski, Anil K Giri, Tero Aittokallio
Nucleic Acids Research (2022) Vol. 50, Iss. W1, pp. W739-W743
Open Access | Times Cited: 385

Showing 1-25 of 385 citing articles:

Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones
Deguang Liang, Yan Feng, Fereshteh Zandkarimi, et al.
Cell (2023) Vol. 186, Iss. 13, pp. 2748-2764.e22
Open Access | Times Cited: 322
Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer
Julien Dilly, Megan T. Hoffman, Laleh Abbassi, et al.
Cancer Discovery (2024) Vol. 14, Iss. 11, pp. 2135-2161
Closed Access | Times Cited: 41
Disrupting pro-survival and inflammatory pathways with dimethyl fumarate sensitizes chronic lymphocytic leukemia to cell death
Maria Elena Mantione, Miriam Meloni, Ilenia Sana, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 20
APOBEC3A induces DNA gaps through PRIMPOL and confers gap-associated therapeutic vulnerability
Ajinkya S. Kawale, Xiaojuan Ran, Parasvi S. Patel, et al.
Science Advances (2024) Vol. 10, Iss. 3
Open Access | Times Cited: 18
RSL3 induces ferroptosis by activating the NF-κB signalling pathway to enhance the chemosensitivity of triple-negative breast cancer cells to paclitaxel
Jialin Yuan, Cong Liu, Chengwei Jiang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Druggable genome screens identify SPP as an antiviral host target for multiple flaviviruses
Wenjie Qiao, Xuping Xie, Pei‐Yong Shi, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 8
Open Access | Times Cited: 2
Expanded profiling of Remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitro
Sheli R. Radoshitzky, Patrick L. Iversen, Xianghan Lu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 35
Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosis
Hanqiang Shi, Lie Xiong, Guang Yan, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 25
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy
Zhangyi Luo, Yixian Huang, Neelu Batra, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Baicalin enhances the chemotherapy sensitivity of oxaliplatin-resistant gastric cancer cells by activating p53-mediated ferroptosis
Lihua Shao, Li Zhu, Rong Su, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 15
EZH2 inhibition sensitizes MYC-high medulloblastoma cancers to PARP inhibition by regulating NUPR1-mediated DNA repair
Jianzhong Yu, Ji-Chang Han, Yu Meng, et al.
Oncogene (2024)
Closed Access | Times Cited: 15
RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade
Marie‐Julie Nokin, Alessia Mira, Enrico Patrucco, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Synergistic Effects of Temozolomide and Doxorubicin in the Treatment of Glioblastoma Multiforme: Enhancing Efficacy through Combination Therapy
Laxmi Dhungel, Mandy E. Rowsey, Cayla Harris, et al.
Molecules (2024) Vol. 29, Iss. 4, pp. 840-840
Open Access | Times Cited: 13
Organoids for Functional Precision Medicine in Advanced Pancreatic Cancer
Alice Boilève, Jérôme Cartry, Negaar Goudarzi, et al.
Gastroenterology (2024) Vol. 167, Iss. 5, pp. 961-976.e13
Open Access | Times Cited: 13
A rapid and simplified DPPH assay for analysis of antioxidant interactions in binary combinations
Fernando Silva, Francisco Veiga, Catarina Cardoso, et al.
Microchemical Journal (2024) Vol. 202, pp. 110801-110801
Open Access | Times Cited: 10
Simultaneous targeting of AMPK and mTOR is a novel therapeutic strategy against prostate cancer
Gangyin Zhao, Gabriel Forn‐Cuní, Marvin Scheers, et al.
Cancer Letters (2024) Vol. 587, pp. 216657-216657
Open Access | Times Cited: 9
The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variants
Aleksandr Ianevski, Irene Trøen Frøysa, Hilde Lysvand, et al.
Antiviral Research (2024) Vol. 224, pp. 105842-105842
Open Access | Times Cited: 9
CYP3A5 promotes glioblastoma stemness and chemoresistance through fine-tuning NAD+/NADH ratio
Wentao Hu, Xing Cui, Hongyu Liu, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1
Tumor Microenvironment Responsive Key Nanomicelles for Effective Against Invasion and Metastasis in Ovarian Cancer Using Mice Model
Yang Liu, Liang Kong, Yang Yu, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 215-238
Open Access | Times Cited: 1
Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancer
Bengul Gokbayrak, Umut Berkay Altıntaş, Shreyas Lingadahalli, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access | Times Cited: 1
IHCH9033, a novel class I HDAC inhibitor, synergizes with FLT3 inhibitor and rescues quizartinib resistance in FLT3-ITD AML via enhancing DNA damage response
Mingyue Yao, Wenzhong Yan, Wang Yf, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 1
SREBF1-based metabolic reprogramming in prostate cancer promotes tumor ferroptosis resistance
Guojiang Wei, Ying Huang, Wenya Li, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Fatty acid binding protein 5 inhibitors as novel anticancer agents against metastatic castration-resistant prostate cancer
Hehe Wang, Chuanzhou Zhu, Manojit Mosur Swamynathan, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 122, pp. 118136-118136
Closed Access | Times Cited: 1
Enhancer transcription profiling reveals an enhancer RNA-driven ferroptosis and new therapeutic opportunities in prostate cancer
Sheng Ma, Zixian Wang, Zezhong Xiong, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Combined toxicity evaluation of polystyrene nanoplastics and Nano-ZnO of distinctive morphology on human lung epithelial cells
Heng‐Hui Li, Shaowen Tang, Xiaoyu Jia, et al.
The Science of The Total Environment (2025) Vol. 973, pp. 179097-179097
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top